We develop advanced tools at the intersection of molecular science, bioinformatics, and artificial intelligence. Our suite of products is designed to provide clinicians, researchers, and pharma/biopharma partners with high-resolution, real-time insights to improve cancer diagnosis, monitoring, and treatment. Each product is purpose-built to address the most pressing challenges in precision oncology — from capturing rare circulating tumor cells to unlocking singlecell multi-omics data.

Explore our portfolio below and discover how our technologies are reshaping the future of cancer care.